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z-1
Int roduct j on
ln 1984, the Commiss'ion in a Communication to Councit stressed,
the need for cooperation at Community LeveL on priority issues in
the heaLth fieLd *. Therefore, in the Communication to Council
entit Led ,'Action aga'inst Cancer'r the Commission weLcomed the
initiatives Launchedat the MiLan and Luxembourg Summits *t-
At the CounciL of Ministers of Fore'ign Affairs of 16/17 December
1985, it was agreed that the Commission woutd convene an ad-hoc
committee of experts in order to advise on priority act'ions and
the ways and means for their impLementation, and a report wouLd
be made to CounciL. The experts met in Brussels on 24 January,
and 'in Paris on 19/?0 February 1986. *** The present document
is an interim report.
Conc tus i ons of exp .
The ad-hoc committee of experts emphasised that mortaLity due
to cancer is continuousLy increasing in Europe. To face this
grow.ing threat to human tife, support for basic, epidemioLog'icaL
and cLjnicaL research on cancer shouLd be sign'ificantIy increased
together with wide ranging actions on prevention. The measures
suggested represent first steps in this direction and they shouLd
be foLLowed by more ambitious programmes- Such programmes shoutd
be carried out in a coordinated way, in order to achieve a criticaL
LeveL of efficacy and avoid dupIication.
t C0l'l(84) 502 finaL
xi COtvl(85) 799 finaL
*** The report of the meeting is annexed.
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2.2 For exampLe, trials of lleatgqn! represent a basic tooL for
the pursuit of therapeutic progress. In severaL Member States,
nationaL bodies are carr),ing out cooperat ive str.rdies and some
Large institut'ions ale abrLe to penf ornr the.ir ot.ln triaLs f or
common cancers. lnievertheLess studjes at Community leveL are
essent iaL because f or unciommon cancers/ even .i n the largest
Member State, the number of pat'ients is too smaLL to achieve
a satisfactory resuLt. f:urthermore, there is a growing tendency
for the statisticaL desigln of such triaLs to require larger
numbers of pat ients; ancl finaL Ly" treatments must be evaLuated
quickLy in order to make the possibLe benef.its avaj LabLe to
a L L pat i ent s wi thout de Lay.
2.3 For aLL these reasons, the experts feLt that support shouLd be
given to European organizations coord.i nating cl"inicaL trials.
2.4 To support such an increased #g3.t effort/ accurate information
on the occurrence of cancer is necessary for pLann.ing and
evatuation of cancer controL meagures. Cert'ification of the cause
of death 'is obLigatory in alL Member States and th.is serves as
a bas'i s f or rrtortaLity statist ics. Ho!.lever, detai led information,
vital for nesearch, is not unjforrnLy avaiLabLe: it must be made
so if it is to serve as a basis for epidemioLog'icaL research and
for monitorirrg the effects of prevention and treatment throughout
the Communi ty.
2-5 In addition,cancer reqistla:L!-gn and cancer registries shouLd be
promoted by estabLishing the LegisLative bases enabLing aLL Member
states to contribute to a comrnunity data base. The r;xisting rutes
on confidentiaLity'i n som,e Member states which encourage high
quaLjty epidemioLogicaL research shi:r.rLd be extended to the vihers
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and aLL tegistative restrictions against cancer registration which
hamper epidemioLogicaI research shouLd be aLLeviated, in order to
create a Community research forum.
2.6 Addressing specific topics, the experts agreed that lg!ry is
by far the most common carcinogenic agent in our environment and
nothing ulouLd be more effective for reduc'ing cancer than reducing
tobacco consumption. In the commun'ity approximateLy one in four
of atL cancers'is attributabte to smoking. It causes about 80 z
of aLL Lung cancers, and it is aLso associated with cancers of
the mouth, Larynx, bLadderrpancreas and poss.ibLy other organs.
Moreover tobacco is atso at the root of a Large proportion of
deaths from cardio-vascutar and chronic respiratory diseases.
2.7 The cancer risk of active inhatation of cigarette smoking has been
firmLy documented. But the risksof passive smoking are not yet
properLy known and further research into the effects of passive
smoking is recommended. In add'ition anti-smoking campaigns in
some countries have Led to the adoption of tobacco-chewing by
the young in particular. However, the chewing of tobacco is aLso
carcinogenic and it is not a safe aLternative to cigarettes.
The consumption of non-smoking tobacco products shouLd therefore
be strongLy d'iscouraged, and anti-smoking campaigns shouLd be
evaLuated to ensure that smoking is not repLaced by an increase
in tobacco chew.ing.
2.8 The experts stressed that the highest priority in cancer prevention
shoutd be given to the controt and eventuat @.
The aim must be to reduce the prevaLence of smoking by stopp.ing
peopLe, especiaLIy chi Idren, from starting to smoke, and by
assisting smokers to quit. For those who find it difficuLt or
impossibLe to give up smoking attogether, a reduction in the tar
teveLs of cigarettes might Lessen their risk.
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2.9 It 
'||as agreed that $.glgtl@, jncLuding atcohol, canjncreaSe the riSkS Of Severrat COmmOn CanCerS. HOwevert more
research is necessary before specific measures can be proposed,
and such research shouLd be encouraged at Community LeveL taking
advantage of regionaL difl'erences in cancer incidence and dietary
habits, and recent change$ in dietary patterns. Another priority
for research in this fieLcl is the deveLopment and vaL'idat'ion of
anaLyticaL methods to dettlrmine exposure of humans to carcinogens/
mutagens as tdeLL as to identify unknown carcinogens. Efforts must
a[so be directed towards lthe design of a common methodoLogy for
the assessment of the prorlective effect of certain nutritionaL
component s.
?.10 For prevention by earLy diagnosis and treatment, screen'ing for
cancer of the cervix uterj is cLearLy effective'in Lowering
the inc.idence and mortaIity of the disease, when aLL women in
certain age groups in a given region are personnaLLy invited to
participate. In addition there are encourag'ing indications that
mammographic screen'ing for cancer of the breast may resuLt in
a reduction of breast cancer mortaLity. Therefore, there 'is
a need to consider how to promote popuLation based screening for
cancer of the cervix uteri in aLL Member States; to exchange
'information on current reSuLtS of mammographic screening for
cancer of the breast; and to promote research on screening for
other cancers.
2.1 1 Last Ly, but of
from exposures
the workpLace.
a Leg t s Lat'l ve
exposures and
equal importance, occupat'ionaL canc,er may resutt
to chemicats, or to comp[ex chemicaL mixtures, in
Actions at Community tevet have aIready provided
base for thre controt of occupationaL and enviranmentilI
such activ'ities shouLd be reinforced and acceLerated '
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?.12 In support of these actions a broad-based jljg!g3l!@
education programme was proposed directed towards the heaLth
profess'ions, speciaLists in cLinicaI oncoLogyrresearch workers,
patients and the generaL popuLation, with special attention to
certain groups such as chiLdren.
2.t3@,j1.reasedemphasjsoncancershouLdbegiven
at each stage of training and spec'iaL programmes are necessary
for the continuing education of famiLy doctors and generaLists.
For research workers a programme of exchange feILowships shouLd be
estabLished.
2.14 For patients and the community, cancer education shou[d be part of
generaL heaLth education and particutar attention shouLd be given
to specific opinion infLuencing and behaviour modifying groups,
eg.teachers. In addition, the proposaL to have a weLL thought
out initiat'ive such as a European cancer week was supported.
The core of such an event to be hel.d in 1987/88 should be an under-
standabLe and concise message. The Community nature of such
a campa'ign must be stressed and it should invotve the nationaL
Leagues and organisations against cancer.
3. Community actions in research and prevention
3.1 To deveLop !ggp,g.13!g at Community tevet on 'Action aga.inst Cancer ,
the Commission wiLt shortLy make a proposaL for a CounciL Decision
renewing the MedicaL and PubLic HeaLth research Coordination Programme
(1987-89). This wilL contain a spec'iaL cancer sect'ion.
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3,2 AIL Member states have Lorrg experience and considerabte resources
engaged in cancer IgsE3-cgL However, most nationaL programmes
cons.ist of a Large number of reLativeLy smaLL projects carried out
in separat.e institutes. .].he Commission wi LL, therefore, seek to
co-ord.inate and support the retevant parts of nationaL programmes
with a v.iew to increasing their efficiency and improving the outcoms'
3.3 Certain actionP'in the areas
and diagnosis, and nutrition
these, the new ProposaL wiLt
cLinical toPics and research
of cLinicaL research, earty detection
are aLready underulay and to deveLop
address basic, epidemioLogicaL and
t ra i ni ng, as fo L Lows
deveLop'ing better non-'lnvas'lve
L cancers and PremaL'ignant
cLinicaL treatment research, by deveLoping and improving
controtLed cLinicat triaLs of muItimode treatment (surgery,
radiotherapy, chemotherapy, immunoLogy' etc ' ) '
Drug deveLopment, by deveLoping net.l approaches using mathematic
modeLLing, moLecuLar inraging techniques, and advanced'in vitro
screening methods for cletection of moLecutar activity'
EarLy detect'ion and 4iergnosis, by
diagnostic methods to cletect smaL
cond'itions.
EpidemiotogicaL research, to quaL
cancer and estabIish rtlLationship
cance r.
Training feLtowshiPs to
training'in institutes
ify and quantifY occuPationat
between dietarY factors and
enabIe researchers to extend their
'in other Member States.
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3.4 In addition,
to the Counc
.t
P revent'l on .
-
the Commiss'ion has aLready submitted a proposaL
'iL for a ResoLut'ion on a Programme of Action on Cancer
?q This Action Programme on Cancer Prevention identifies the
objectives of halting the increase of cancer in the Commun'ity'
Leading to a downward trend in both incidence and mortality from
thed.isease,anddecreasingthepotentiaLyearsofworthwhiLeIife
Lost as a result of the disease' The programme should aLso Lead to
increasedknowLedgeaboutthecausesofcancerandthepossibLe
means of prevent'ing and treating it' The CounciL is being asked
to support priority actions in the fieLds of tobacco smoking'
nutrit.ion and aLcohoL, services for screenlng and earLy diagnosis'
heatth education and canceli nformation' ParticuLar
emphasisisputon.improvedcoLLaborationwithnationaLand
'internat'ionat agencies in the fieLds covered by these actions'
3.6Thepreventionofoccupat.ionaLcancerswasident.ifiedasamatter
for priority action in the CounciI Resolution of 27'?84 on a
Second Programme of Action of the European Communities on
Safety and Hea[th at Work **'
Information and Training4.
4.1 A European Campaign of Informat ion about Cancer in
to the public the substance of
other singLe message couLd have
a Citizens'EuroPe.
the same emotionaL
1987 cou[d demcnstrate
Poss'ib LY no
appea [ .
l|.2IobeeffectivethemessageshouLdcomefromexpertsinthecancer
fieLdandbepresentedbyexpertsinthefietdsofcommunicationand
themed.ia.ThecampaignshouLdbedes.ignedtoachieveahigh[eveL
ofcoordinationbetweenMemberstatesand.itshouLdtakepLace
336 28.12.85
67 8.03.84
I 0J c.
*x 0J c.
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s'imuLtaneousLy throughout the Commun'ity in order to have
the desired effect. To these ends it wouLd require carefuL
pLanning and jnvoLve representatives of Member states to agree
on precise objectives, the heaLth professions to gain their fuLL
support and cooperation and those responsibLe for its praticaL
preparation and conduct-
4.3 Act'ions'in the fieLd
the Action Programme
heaLth education are contained'in
Cancer Prevention. TheY envisage
invoLving individuaLs, parents and group Leaders with teachers,
heaLth-care workers and media professionaLs'in a process of
information exchange and training. In addjtion, the commission
wi LI continue estabLished activities in more generaL aspects of
heaLth education. Actions, in the fieLd of medi caL educat'ion at
community IeveL come w'ithin the context of approving the tra'inin9
of medicat students, doctors and spec'iaLists for the mutuaL
recogn'ition of dipLomas arrd rights of movement and estabLi shment '
5. ReguLatorY actions
5.1 Community tegisLation to reduce the risk of cancer in the popuLatior
has been enacted'i n a numtrer of fieLds e-g. radiation protection,
agricuLture, envi ronment and pharmaceuticatsx. Throughout thei r
discuss'ions the experts made particuLar reference to this and
attached great importance to such reguLations as providing an
essent.iaL basi s, or an essentiaL compLement, to other actions
Limiting accidentaL or unintended effects and'infLuencing indiv'iduaL
and group behaviours. Threr€ llJas a consensus to urge the CounciL
and the commiss'ion to intensify work in estabLished fieLds and
to extend this work into the fieLds of smoking' nutritjon and
'i nf ormat i on sYstems .
t An overview of existing cOmmunity actions against cancer.
(Com(85) 799 tina[, annex)
of
on
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6- Esqsgl
6.1 Acting upon the conc[usions of the Counci L of ftlinisters of
Fore'ing Affairs, 16/17 December 1985, the Commission has committed
2 miLLion Ecus for actions in research and prevention of cancer during
1986-
6.2 The Commission wiLt shortty submit to the CounciL its budgetary
proposats in the area of research against cancer.
z- @Lg:lrn'
7-1 The Commission wishes to acknowtedge with thanks the work of the
ad-hoc advisory committee of experts.
7.2 The Counci[ 'is requested to note its recommendations in the fieLds
of research, prevention, health education and pubLic information,
and regu[atory actions as summarised in this report.
7.5 The CounciI is requested to examine as a matter of priority
the proposa[ for a Couci L Resolution on an Action Programme of
Cancer Prevention which embodies a[[ of these recommendations as
concern prevention and heaLth education.
7.4 The CouciI is requested to note the intention of'the Commission
to submit proposats on re,search and, as part of a Citizens'
Europe, a European Campaign of Information on cancer.
7-5 The Council is requested to note the intentron of the Commissron
to intens'ify wonk reLating to cancer in aIL other Community pro-
grammes and bring forward proposaLs.
ANNEXE
Conclueion of the Ad Hoc Commlttee of Experts on Cancer
- t'leettng ln Parie' t9-2o February 1985'-
t.
ANNEXE
-1-
The ad hoc commlttee of Experts wlth the asslgtance of
lnvlted expertg rn the three eubgroups on preventlon,
reEearch and educatlon, agreed as followe:
r .1.
1.I . 1.
1.1,2.
I .1.3.
1.1.4.
r. L.5.
Prevention, lncludlng actions on tobacco, occupatlonal
cancerr cdnC€r reglstratlon, earl-y detectton, nutrltlon
and lnternatlonal collaboratlon.
Tobacgo
Tobacco ls by far the most common carclnogenic agentln our envlrorunent and nothlng wourd be more effectlvefor reduclng cancer mortality In Europe than red,uclngtobacco consumptlon. rn European counlrleg between r5t
and 3Ot of all cancers are altrlbutable to ernoking. It
accounts for about 80t of lung cancersr and ls also
assoclated with cancere of the mough, Iarynx, bladderpancreaE and possrbly other organs. Moreover tobacco lsalso at the root of a large proportion of deaths from
cardio-vaecular and chronlc respiratory dleeasee.
The hlgheet prlorlty 1n cancer preventlon ehouLd there-fore be glven to the contror and eventual erlmlnatron
of tobacco.
The alrn must be to reduce the prevalence of smoklng by
stopping people, especla.Ily chlldren, frorl startlng- to
smoker and by aesistlng those who already smoke t,o qult.fhere are some people who flnd lt dlfftcurt or rmpoieibreto glve up smoklng arrd for them a reductton tn thl tarlevels ln clgarettes may lessen thetr riek.
Anti-smoklng campalgne ln come count,rl,ee have Led to the
adoptlon of tobacco-chewlng by the young ln part,lcular.Hovrever, the chewlng of t,obacco la algo carcinogenlc andlt is therefore not a.eafe alterrrative to algarettee.The conaurnptlon of non-gnoking tobaooo productg shourdtherefore be st,rongly dlscourigedr and Lnti-smoklng
campalgne ghould be monltored to ensure that smoklng ls
not, replaced by an Lncreeee ln tobaooo oher,rlng.
The_ carcinogenic rlsk of active lnhalatlon of clgarette
smoklng hae been flrmly documented but the level of rlskof paaeive smoklng is not yet known. Further researchlnto the effecte of paaslve emoklng ls recommended.
There ls a need for behavloural- and soctal research todetermlne the moet approprtate methoda of educating
chlLdren agalnot the uEe of, tobacco, and to aeelEt-
smokers to glve up the hablt.
r.I.6 .
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L 1.7. The ad hoc commlttee of experte therefore reguests the
Comrnlgelon bo develop propoeals for a Etrategy almed
at discouraglng the product{on',, sale and use of tobacco
tnaterlal. These shouLd lnclude the followlng lnnediate
actlons !
- dlscontlnuatlon of dleEemlnation of cheap
tobacco products (e.9. low prlces and taxfree sales)
- excluElon of tobacco products from the costllvlng lndlces ln Member States
Further actlons should, lnclude:
prohlblt,lon as soon as practlcable of advert-
lsements ln any form of tobacco products
lncreased educatlon of the pubtic from the
earlleet ege posstbler with the alm ofprevenfing persons to take up smoklng, and
to rnake smokerE give up the habit
each pack of clgarettes should carry a health
warning
the uee of :non-smoking tobacco products shouldbe discouraged
a declaratlon of tar contents shcluld be gtven
on tobacco 'products
taxatlon of cigarettes proportlonal to the taryield of clgarettea.
srnoklng in public places should be regulated
r.2 .
r.2.r.
L,2 ,2 ,
Occupatlonal Cancer
Occupatlonal cancer p:rovides important exanpleg of
cancers resultlng from expoBuree to chemtcaLs or to
complex chemlcal nlxtures, whlch may also occur j.ndlf ferent envlronmentg.
Actlons at Communlty .level Berve aa & bagls for regulatllrrs
of envlronmental and rlccupablonal carclnogenic expoeures ;ln
Member Stabee. Such ongolng actlvltles should be streng€hened
and epeeded up.
Epldemlologlcal regea:rch to qualify and quantlfy occupatlonal
cancer riske as $rell rts f,€B€arch In ldenttfylng new carcl.-
nogens should be strenghtened and promoted. To achleve tl:[s,
employere should keep etxployment recordB of indlvldual
employees and such rer:ords should carry tdenttfylng lnfor-
matlon and lnformatlon on Jobe and expoaures. Such recorls
1.2 .3 .
L,2 ,4 .
1.3.
I.3 .1.
1.3.2.
1. 3.3.
r.3.4.
1.4.
I.4.I.
ANNE XE
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ehould be kept wlthout tlme limtts and provieione should
be made nationally for storage of such records. Records
should be avallabl.e to medlcal researchers for epldemlolo-glcal etudtesr 
€.9, for llnkage wlth cancer regletry
lnformatLon or death cettiflcatee.
The Internatiorral Agency for Researoh on Cancer would forrn
a eultable body for organlzlng multl-national research,
and enaure also collaboratlon wlth non-EEC countrLes.
Cancer regt*qtrgtloll
Accurate lnformatlon on the occurtrence of cancer i6important for plannlng and evaluatlon cancer control
meaaures. Therefore, populatton based cancer reglstratlon
1n the European Community should be promoted in order to
obtaln lnformation on the lncldence of canc€r.
It le necessary to establieh legielative basee enabllng aII
Member $tates to carry out epldernlologlcal surveys and topromote cancer regletratlon. The rules reoulating
confidentlal.lty whlch are ln use in aome Member States, and
t+htch encourage hlgh quallty epldemlologlcal research, shouldbe extended to otherE and all leglalat,lve reEtrlctlone
agalnst cancer regletratlon which hanper epidemiological
regearch shouLd be allevlated, ln order to create a
Communlty epldemlologlcal research forum.
Comparablllty of lnformatlon both between reglstrlee lnelde
the Communlty and wlth lnformatlon from reglstrles from
olher parts of the world muet be engured, The Internatlonal
Agency for Research on Cancer asgletlng the Internatlonal
Assoclatlon of Cancer Reglstrles already plays a crucial-
role in coordinatlng cancer reglstratlon efforts throughout
the world. Expert advlce on cancer regLstratlon should be
sought from them.
Certlflcatlon of the cauee of death is obligatory ln all
Member Stateg, and gervos as a bagis for mortality
etatietlcs. Information on cancer mortallty should be avallable
ag a baels for epldemlologlcal reEearch and for monltorlngthe effects of preventlon and treatment in all EEC countries.
Earlv detectlon
Ecreenlng for cancer of the cervix uterl is clearly
affectlve ln lowerlng the incidence and mortalLty ofthe dj.seaee, whEn all women of glven age groupe ln agiven reglon are perBonally lnvlted to partlcipate.In addltlon thare are efiicouraglng lndications that
marunographlc screening for cancer of the breast may
result ln a reductlon of breast cancer mortallty. For
other cancers there ls at present no evidence of thebeneflcLal effect on mortaltty by screenlng.
r.4,2 .
f.5,
I.5.I.
1.5 .2 .
1.6.
I.6 . I,
1,6 .2 ,
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The ad hoc commlttee of experts requeste the commtsstonto consider the pronotion of popuration based screeningfor cancer of thl cervlx uteri in alr Member states, -;n
exchange of lnforhation to evaluate current re$ults of
mammographrc ecreening for cancer of the breast; andthe. promotion of research on screenlng for other caneeresuch as cancer of the coLon, melanoma of the ekln, andcancer of the ora] cavity in high incldence reglons.
Nutrltlon
Evldence strongly eugEests that dietary factors, includin,JaLcohorr cah greatly modlfy the rlsk oi several freguenthuman cancers. rurthe,r reslarch is however felt n".6esurybefore epec{flc measures can be proposed, and euch researr:hshould be encouraged at communrty rlverr'tutingadvantage of regionaL dlfferences ln cancer lnildence dfl,ldletary hablts, and recent chanfes in-aiut*ry patterns.
ll?il::,prlorlty lrga for research ts rhe devetopment an,lvarldatlon of methodg for analyslng blologlcar tiulds anrltl-ssues ln ord,er to determine exposure of -humans a;-carclnogens/mutag€nE aE weLr as 'to identlfy unknown carc L-nogeng. Effortg shoutd almllary be dlrectel towarde thedeslgn of a conmon met,hodorogy for the asseggment of theprotectlve effect of eertaln nutritlonal, componentg.
I,nternational collaboration
The rnternationar Agerrcy for Research on cancer ln Lvonprays an lmportant par:t ln epidemtoroglcar reEeai"n-6"-cancer, whlch formg arr lmportant basii for cancer prevent;ion.
The ad hoc commtttee of expert,e therefore requests thecommlgglon to conalder how- the Agency could rie atienflner,eato,take part in tho Action progrimma on cancer ln Europe.
Thl" mlsht, be achteved by urgrig countrr.es 
"i-thr eEi-loJp1"_!!. Agency'e memberihtp-an6 arso by Jolnt *ori.u"ir."r,the CEC and the IARC. -
Res,earcir lnctgdlng cllnlcar reaearch, research followehlps,
a communlty drug deve'roprnent progtramme, a European animal
celr colrectlon servrce. The ad hoc commlttee of experts
observed that mortarity due to cancer is continuouery
lncreasLng ln Europe. To face thts growlng threat to human
ltfe' support for baelc, epldemiorogicar and crlnlcar resaarch
on cancer should be elrgnlftcantly Increaged. The meaeures
suggested repreeent a flrst step ln thls dtrectlon. They should
be followed by more amlcltious programmes. rn order to acl;Leve
a crltical revel 0f ef:Eicacy and avoid dup'1cat10n, such
z.
2. r.
2. I.I,
2,L.2,
2.L.3.
,.r.o.
ANNEXE
-5-
^programmes should be carrled out ln a ,coordlnated waylncludlng compet,ent centers ln the Member Statee.
Cllnleal reaeargh
Controlled cllnlcaL trtaLs repreeent a basic tool ln
therapeUtlc progrosE. In several Member Stategr nationalbodiei are cirrifttg out cooperatLve therapeutlc trlale
and some large lnetitutions are able to perform thelr
own trlale for common cancers.
Neverthelese studles at Cpmmunity level haVe eevcral
advantages:
a) For uncomnon cancers, €ven ln the LargeSt Membcr State'
the annual patlent accrual ls too small for the successful
organJ,zation of a controLled trlal. Internatlonal co-
operation lE therefore mandatory'
b) [here is a growlng tendenoy ln trials on the common
cancers towird, the stratification of the patlentE
accordlng to Eeveral charaaterlstlcs, AG a result
the number of patlente who need to be entered lnto
euch trial.e iE beconlng larger.
c) It tE dlfftcult to complete a trlal
of time, in 6pite of the faot, that'
perf,orm a trtal raPldIY.
For all thosc raa6ong, the ad hoc comnlttcr of rxprrtrfeels that Eupport ehould be gtven to European organl-
aattonE coordlnatlng cltnlcal trtals. Ehe European. Organi-
aatlon for Reeearch and Treatment of Cancer (EORTC)" Ls a
maJor organlzatlon whlch has a long tradltion ln thls fteld
and over-the IaSt ten yeara has entered ovar 30 OOO patlentsIn trlals.
Increased financial suPport to EORTC would enable thls
organlzatlon i
- to enlarge the number o! patlgntt cntered caoh yearln cltnlcal trlals,
to lmprove the technlcal levet of the computerfacltttleg at the BrusEels Data Center t
- to organfze a network of European Data centers whlch
coul,d promote the exchenge of data r
- to revlew and coordlnate ongoing cllnlcal trLals,
to brtng togethcr cllnlolant and other sclentlat'a ln
ord,er t5 funlrove the quallty and to speed up the
dPveloprnent of new treatments.
ln a short periodlt tE prafcrable to
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2 .1.5 .
2,2,
2,2,L,
2,2.?.
2.2.3.
2,2,4.
2.2,5.
2,3,
2.3.L,
She ad hoc cOmtnlttee of experts reconunends that, as an
lmmedlate step, the 1986 EEC allocation to the EORTC should
amount to about 4OO.OOO ECU9. It iE flrmly belleved thatthls Eupport would provldE an lmprovemrnt ln tho general
leveL o!-cllntcal research and tieatment in the Comnunlty.
Re a, gFrch f€l_lowehip s
Tha ad hoc committee, of experte belteves that Communltlprlorlty ehouLd be given t,o the eetabllshment of a
Communlty Cancer Research Fellowshlps Programme.
It ls ertlmated that; 5O fellowships are requlred. Thig
nurnber may be reachad ln stages, startlng at a mlnt-
murn leveL of 25,
The purpose of lheEe fellowshtpe ls to enable reaearch
workere- from any Menrber State tO work in collaboratlOn
wlth outstandlng cll.nlcal or fundamental cancer lnvest''lgator.s In another European country. Short-term f,e1low''
ships (up to 3 monthe) and Long-term f,el.lowehJ.ps- (I ye:'r,
renewable once) sholtId be avallabl.e. The f,ellowahips
shOuld be awarded for oancer research work ln the areetll
of baslc laboratory' epldemiologlcalr Errd cllnlcal rostrarch'
Appllcants must have a doctoral degree (or an equl.val6rrt,
degree) or be medlcally quallfied. They must submlt a
reiearch plan r*hich would Eerve for evaluation of the
applfcatt6n. Awarde would be made on the basis of advl,<re
of a panel of aclentlific exPerts.
Appllcationei once a year for the long-term fallowshlptl
no dead-llne for the ghort'tetm fellowah:.prs
Elnanclal support: $ame as EMBO fellowshlps
It ls r6cornmended tttat, the prografilme couLd be extendedto EFTA countrleE wj"IIlng to partlclpate'
DT.ggr development
Drug development ptays a cruclal role ln the f tght 
_aga:.rrEtcanier. Tho-nred for ncw compounds rcnalns urg.nt deep:.tc
a host of establlEhed agentB avalLable. Therefore, the tlme
taken to make a new drug avallable !n all, European coutttrlee
should be reduced fr:om the unacceptably long perlod
exletlng at present" There is a need for conunon guld€I:,treafor tha-conduct of Iluropean studlee on the pre-cllnleai.
and early cllnlcal aEses3ment of antt-cancer drugs.
\
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2. 4, lnlm.Fl_cel1 collecJlogJeFvdse
The ad hoc cornrnlttee of experts was pleased to learnthat the EEC ls presentl! contributing to the support
of a European cell collectlon where tumour cell lines(lncludlng hybridomag) can be stored and made avallableto European researchers. It le consldered that thts inportantfacllity ehould be malntalned and developed.
3. Educatlon lrroludlng eduoatlon and lnf,ormatlon to the gencral
publlc and professional educatl.on
3, l. Generel public
3.1.2. It ls recommended that the oancer educatlon of the generalpubllc should be a part of general health educatlon.Partlcular attentlon should be glven to epeciflc opinionlnfluenclng and behavLor rnodlfylng groups (L.e. teachers, etc. ).
t.1.1. In addltlon, the proposal to have a well. thought
out Lnltlatlve auch as a European cancer week ls
recommended. An understandable and ooncLge meE5agc
should make up the core of such an event to be he1.dln L987/88. trhe Communlty nature of thlE lnl.tlatlve ls to be
stressed and lt ehould lnvolve the national leagues and
organleatlona agalnet canc6r.
3.2. ?,{of,eEsional" educatloTt
3,2.1. Undergraduatest nember countrles should have a prof,essorln oncology ln alL teaching medical centers offerlng abroadly baeed programme from the epldemlology and prlnclplea
of preventlon to early deteation treatment and termlnal
care. The programme should conslst of a ml.nl.mum of 3O houre
teachlng tl,me and concentrate on the 10 major tumour eltes.Flnally, an examinatlon ln oncology ghould be part of every
medlcal Echool cutrrlcuJum.
3,2,2. General practltlonersc theEe form a prlorlty group for
cancer education. Thls shoul.d form part of a contlnulng
education progranme for.general practitionerE ln whloh they
will be strongly encouraged to participate. A perlodlc
neweletter or bul.letln should be congldered at natlonal.level .
3.2.3. oncologlsts! each Member Stat'e should recognize the speolalty
of oncoLogy. The trainlng for such a epeclalty shou}d be
unlform between the Member Statcs. Spaclal consLderatlona
should be glven to the tralning and recognJ.tton of spectallsts
who have developed a maJor lnterest ln speolflc cancere,
A Comnrunlty progranme for tr&lnlng and aontlnulng educatlonln oncology (excludlng mectlnge and oongresses) ehould be
developed and lnlttattvee f,or developlng educationaL programmsafor oncologlste shouLd be eneouraged.
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